Medanta Operator Global Health IPO: GMP, Subscription Status on Day 2 of the issue

Medanta Operator global health ipo Have a fresh issue up to 500 crore and offer for sale of 5,07,61,000 equity shares. Its price range is at . Is 319-336 per share. Global Health said on Wednesday that it is mobilizing 662 crore from anchor investors. At the upper end of the price band, the company expects to achieve 2,206 crore through IPO. The proceeds from the fresh issue will be used to pay off debt and general corporate purposes.

As per market observers, Global Health Shares are available at a premium (GMP) 15 in the gray market today. The shares of the company are expected to be listed on the major stock exchanges BSE and NSE on Wednesday, November 16, 2022.

“Global Health’s hallmark is the Medanta brand and Dr. Trehan’s reputation apart from the flagship “Medanta the Medicity” hospital, Gurugram. At the upper price band, it is valued at ~21x FY22 EV/EBITDA. Brokerage ICICI Securities said in an IPO note. That said, we provide membership ratings based on financial recovery, good valuations and increasing investor interest in hospitals.

Founded by Dr. Naresh Trehan, a renowned Cardiovascular and Cardiothoracic surgeon, Global Health is a leading private multi-specialty tertiary care provider in the North and Eastern regions of India.

It provides health services in more than 30 medical specialties and engages over 1,300 doctors spread over an area of ​​4.7 million square feet (sq ft). The main specialties include cardiology, cardiac science, neurosciences, oncology, digestive and hepatobiliary sciences, orthopedics.

Its flagship Gurugram facility was ranked as the best private hospital in India for three consecutive years in 2020, 2021 and 2022, and was the only Indian private hospital to feature in the list of top 200 global hospitals in 2021.

The views and recommendations given above are those of individual analysts or broking companies and not of Mint.